Data protection Impressum

Healthcare

Biopôle-based start-up Vanarix has secured CHF 4 million to initiate new clinical trials and automate the manufacturing of its Cartibeads.

Vanarix raises CHF 4 million to advance cartilage regeneration

15 July 2024

Global demand for biologics is at an all-time high, and Western Switzerland is positioning itself as a key player in meeting that demand.

Biomanufacturing in Western Switzerland

The canton of Neuchâtel is positioning itself as a future leader in medical diagnostic technologies with the creation of a new innovation cluster.

Neuchâtel embraces innovation in medical diagnostic technologies

8 July 2024

Revinax, founded in 2015 by neurosurgeon Maxime Ros in Montpellier, has decided to expand its activities by setting up at the Biopôle in Lausanne.

French company Revinax establishes operations at the Biopôle in Lausanne

3 July 2024

BioAlps, the life sciences cluster of Western Switzerland, offers a dynamic network, an innovative and supportive environment and direct access to the region's vibrant life sciences ecosystem.

BioAlps, Western Switzerland’s life sciences cluster

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (June 2024)

26 June 2024

iOnctura has secured EUR 80 million in a Series B funding round to advance innovative cancer therapies, with a focus on neglected cancers such as uveal melanoma.

iOnctura secures EUR 80 million Series B financing to advance cancer treatments

25 June 2024

Doctolib, a leading European healthtech company based in Berlin, has announced the acquisition of Typeless, an EPFL spin-off specializing in AI speech recognition technology.

Doctolib acquires Typeless to enhance AI capabilities in healthcare

24 June 2024

DAAV, a pioneering start-up enhancing mobility for people with reduced mobility, has raised CHF 1 million.

DAAV secures CHF 1 million to revolutionize mobility services

27 May 2024

Vaud-based life sciences company Limula has secured CHF 6.2 million to democratize access to life-saving cell and gene therapies.

Limula secures CHF 6.2 million to advance automated cell therapy platform

21 May 2024

1 … 14 15 16 17 18 19 20 21 22